Conference Program Home
  My Program

All Times EDT

CC = Walter E. Washington Convention Center   M = Marriott Marquis Washington, DC
* = applied session       ! = JSM meeting theme

Activity Details

481 Wed, 8/10/2022, 2:00 PM - 3:50 PM CC-140B
Dose Finding, Dose Selection, and Early-Phase Trials — Contributed Papers
Biopharmaceutical Section
Chair(s): Na Hu, BI
2:05 PM A Comparative Study of in Vitro Dose-Response Estimation Under Extreme Observations
Xinying Fang, Pennsylvania State University; Shouhao Zhou, Pennsylvania State University
2:20 PM Machine Learning in Pharmacogenomics
Jackson Lautier, University of Connecticut; Junghi Kim, Food and Drug Administration (FDA); Jessica Kim, U.S. Food and Drug Administration; Stella Grosser, U.S. Food and Drug Administration
2:35 PM Early Completion of Model-Assisted Designs for Dose-Finding Trials
Masahiro Kojima, Kyowa Kirin Co, Ltd.
2:50 PM A Non-Parametric Bayesian Approach for Monotonic Dose-Response Model
Nairita Ghosal, Merck & Co., Inc.
3:05 PM Comparison of Dose Limiting Toxicity Rates for Bayesian Dose Escalation Designs
Richard John McNally, Labcorp
3:20 PM Justifying a Sample Size in Phase 2 Dose Selection Study Using a Bayesian Meta-Analytic-Predictive Approach with a Robust Prior Component
Mehreteab Aregay, Daiichi Sankyo Inc
3:35 PM Floor Discussion